These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12087276)

  • 1. Going off-label with breast implants.
    Dowden RV; Reisman NR; Gorney M
    Plast Reconstr Surg; 2002 Jul; 110(1):323-9; discussion 330. PubMed ID: 12087276
    [No Abstract]   [Full Text] [Related]  

  • 2. The FDA approves saline-filled breast implants: what does this mean for our patients?
    Rohrich RJ
    Plast Reconstr Surg; 2000 Sep; 106(4):903-5. PubMed ID: 11007408
    [No Abstract]   [Full Text] [Related]  

  • 3. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
    Jarcho DG
    Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730
    [No Abstract]   [Full Text] [Related]  

  • 4. New female condom clears FDA committee. Next for FDA review: package label and insert.
    AIDS Alert; 2009 Apr; 24(4):42-4. PubMed ID: 19382364
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical device preemption after Medtronic, Inc. v. Lohr.
    Neraas MB
    Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical devices. Label fable?
    Haugh R
    Hosp Health Netw; 1998 Feb; 72(4):82, 84. PubMed ID: 9553521
    [No Abstract]   [Full Text] [Related]  

  • 7. Federal pre-emption under the Food, Drug & Cosmetic Act from Medtronic, Inc. v. Lohr; Pliva. Inc. v. Mensing.
    Ball FR
    Health Care Law Mon; 2011 Sep; 2011(9):2-8. PubMed ID: 21949984
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of Over-the-Counter Hearing Aids - Deafening Silence from the FDA.
    Franck KH; Rathi VK
    N Engl J Med; 2020 Nov; 383(21):1997-2000. PubMed ID: 33207090
    [No Abstract]   [Full Text] [Related]  

  • 9. Silicone breast implants may be close to US approval.
    Ault A
    Lancet; 2003 Oct; 362(9393):1384. PubMed ID: 14594002
    [No Abstract]   [Full Text] [Related]  

  • 10. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 11. Tougher rules on breast implants in Europe: what will they mean?
    Cicchetti S; Santi PL
    Plast Reconstr Surg; 2004 Oct; 114(5):1343-4. PubMed ID: 15457065
    [No Abstract]   [Full Text] [Related]  

  • 12. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 13. The saga of Poly Implant Prosthese breast implants.
    Heneghan C
    BMJ; 2012 Jan; 344():e306. PubMed ID: 22236799
    [No Abstract]   [Full Text] [Related]  

  • 14. Pedicle screws. Lack of FDA approval does not implicate use in hospital.
    West JC
    J Healthc Risk Manag; 1998; 18(2):53-5. PubMed ID: 10185080
    [No Abstract]   [Full Text] [Related]  

  • 15. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]